More than 10 million older adults in the U.S. have mild or greater valvular heart disease and the prevalence is expected to grow over the next several decades, according to data from the PREVUE-VALVE ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...
Wave's pivotal trial, Dr. William Abraham is working on another heart failure trial as the new CMO at Cardiac Dimensions.
In patients with unprotected left main stenosis, there was no difference in all-cause mortality at 10 years between patients who had percutaneous coronary intervention and those who underwent coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results